An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Stevanato Group to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Stevanato Group (NYSE: STVN) announced its participation in two upcoming investor conferences. On June 7, 2022, they will present at the 42nd Annual William Blair Growth Stock Conference in Chicago at 2:40 PM CST. The following day, on June 9, 2022, they will be at the Jefferies Healthcare Conference in New York City at 1:00 PM EST. Live audio webcasts will be available on their website, with replays accessible for 90 days.
Positive
None.
Negative
None.
PIOMBINO DESE, Italy--(BUSINESS WIRE)--
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in two upcoming investor conferences.
On June 7, 2022, Stevanato management will present at the 42nd Annual William Blair Growth Stock Conference in Chicago at 2:40 PM CST and on June 9, 2022, at the Jefferies Healthcare Conference in New York City at 1:00 PM EST.
A live audio webcast will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section of the website. A replay will be available for approximately 90 days after the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.
When is Stevanato Group presenting at the William Blair Growth Stock Conference?
Stevanato Group will present at the William Blair Growth Stock Conference on June 7, 2022, at 2:40 PM CST.
What is the date for Stevanato Group's participation in the Jefferies Healthcare Conference?
Stevanato Group will participate in the Jefferies Healthcare Conference on June 9, 2022, at 1:00 PM EST.
Where can I find the live webcast for Stevanato Group's investor presentations?
The live audio webcast for Stevanato Group's presentations will be available on their website under the 'Investors' section.
How long will the replay of Stevanato Group's presentations be available?
The replay of Stevanato Group's presentations will be available for approximately 90 days after the events.
What does Stevanato Group specialize in?
Stevanato Group specializes in drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries.
